BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27346277)

  • 1. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
    Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
    Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of the Glial Condition Medium in the Nucleus Accumbens Prolong Maintenance and Intensify Reinstatement of Morphine-Seeking Behavior.
    Arezoomandan R; Khodagholi F; Haghparast A
    Neurochem Res; 2016 Apr; 41(4):855-68. PubMed ID: 26547198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
    Attarzadeh-Yazdi G; Arezoomandan R; Haghparast A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():142-8. PubMed ID: 24768984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin/orexin system in the nucleus accumbens as a promising player in the extinction and reinstatement of methamphetamine-induced CPP.
    Amirteymori H; Karimi-Haghighi S; Mirmohammadi M; Majidinezhad M; Khosrowabadi E; Haghparast A
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110616. PubMed ID: 35988849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
    Baracz SJ; Everett NA; McGregor IS; Cornish JL
    Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine.
    Khaleghzadeh-Ahangar H; Haghparast A
    Physiol Behav; 2015 Oct; 149():212-9. PubMed ID: 26057574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate modulates a methamphetamine-induced conditioned place preference.
    Zhu J; Zhao N; Chen Y; Zhu L; Zhong Q; Liu J; Chen T
    J Neurosci Res; 2017 Apr; 95(4):1044-1052. PubMed ID: 27426635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 5-HT
    Shahidi S; Komaki A; Sadeghian R; Soleimani Asl S
    Brain Res; 2018 Nov; 1698():151-160. PubMed ID: 30076792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A wide range of Deep Brain Stimulation of the nucleus accumbens shell time independently reduces the extinction period and prevents the reinstatement of methamphetamine-seeking behavior in rats.
    Eskandari K; Fattahi M; Riahi E; Khosrowabadi R; Haghparast A
    Life Sci; 2023 Apr; 319():121503. PubMed ID: 36804308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin-1 downregulation in the nucleus accumbens promotes methamphetamine-primed reinstatement in mice.
    Huang M; Yan C; Yang X; Zhou X; Lv W; Guo N; Li Y; Bai J
    Neuropharmacology; 2018 Sep; 139():117-123. PubMed ID: 29981334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.
    Narita M; Miyatake M; Narita M; Shibasaki M; Shindo K; Nakamura A; Kuzumaki N; Nagumo Y; Suzuki T
    Neuropsychopharmacology; 2006 Nov; 31(11):2476-88. PubMed ID: 16407899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute and chronic restraint stress on electrical activity of prefrontal cortex neurons in the reinstatement of extinguished methamphetamine-induced conditioned place preference: An electrophysiological study.
    Taslimi Z; Komaki A; Sarihi A; Haghparast A
    Brain Res Bull; 2019 Mar; 146():237-243. PubMed ID: 30660715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior.
    Arezoomandan R; Haghparast A
    Can J Physiol Pharmacol; 2016 Mar; 94(3):257-64. PubMed ID: 26745749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular microinjection of the 5-HT
    Shahidi S; Sadeghian R; Komaki A; Asl SS
    Pharmacol Biochem Behav; 2018 Oct; 173():27-35. PubMed ID: 30077744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.
    Berry JN; Neugebauer NM; Bardo MT
    Behav Brain Res; 2012 Dec; 235(2):158-65. PubMed ID: 22884606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats.
    Parsegian A; See RE
    Neuropsychopharmacology; 2014 Mar; 39(4):811-22. PubMed ID: 23995583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food deprivation facilitates reinstatement of morphine-induced conditioned place preference: Role of intra-accumbal dopamine D2-like receptors in associating reinstatement of morphine CPP with stress.
    Sadeghzadeh F; Babapour V; Haghparast A
    Synapse; 2017 Apr; 71(4):. PubMed ID: 27902847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of the mGluR2/3 agonist, LY379268, into the nucleus accumbens attenuates extinction latencies and the reinstatement of morphine-induced conditioned place preference in rats.
    Baharlouei N; Sarihi A; Moradi M; Zarrabian S; Haghparast A
    Behav Pharmacol; 2018 Aug; 29(5):385-392. PubMed ID: 29462112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.